Hidroclorotiazida Kern Pharma (Hydrochlorothiazide)

Hydrochlorothiazide, the active component of Hidroclorotiazida Kern Pharma, is indicated for several clinical situations involving excess fluid accumulation and high blood pressure.

• Hypertension (high blood pressure)
• Edema associated with congestive heart failure
• Edema due to liver cirrhosis (ascites)
• Edema due to renal disease (nephrotic syndrome)
• Prevention of calcium‑containing kidney stones in susceptible patients

• Hydrochlorothiazide acts by inhibiting the sodium‑chloride symporter located in the distal convoluted tubule of the nephron. This blockade reduces sodium and chloride reabsorption, leading to increased excretion of sodium, chloride, and water. The resulting decrease in extracellular fluid volume lowers cardiac output and peripheral resistance, contributing to a reduction in arterial blood pressure.

Adverse reactions to Hidroclorotiazida Kern Pharma vary in frequency and severity.

Common

• Increased urinary frequency and volume
• Dizziness or light‑headedness on standing
• Headache

Serious

• Severe dehydration or electrolyte disturbances (e.g., hyponatremia, hypokalemia)
• Acute gout attacks
• Allergic reactions such as rash, Stevens‑Johnson syndrome, or anaphylaxis

Before initiating therapy with Hidroclorotiazida Kern Pharma, certain safety considerations should be reviewed.

• Use with caution in pregnancy (Category B) and avoid in the first trimester unless benefits outweigh risks
• Assess renal and hepatic function; dose adjustment may be needed in impairment
• Monitor serum electrolytes (especially potassium, sodium, magnesium) regularly
• Patients with a history of gout may experience precipitating attacks
• Diabetes patients should be aware of possible alterations in glucose control
• Elderly individuals are more susceptible to orthostatic hypotension and dehydration

Hydrochlorothiazide can interact with several medicines, affecting its efficacy or safety profile.

Avoid

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) which may blunt diuretic response
• Lithium, because thiazides can raise lithium concentrations and risk toxicity
• Digoxin, as electrolyte shifts may increase digoxin levels and toxicity

Use with caution

• ACE inhibitors or ARBs, due to additive potassium elevation
• Corticosteroids, which may counteract diuretic‑induced fluid loss
• Antidiabetic agents, because thiazides can enhance hypoglycemic effects